CompletedNCT00641927
Antidepressant Therapy for Bipolar II Major Depression
Researchers compared Venlafaxine and Lithium Carbonate to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Medication studyAges 18+United States
Understand this study
What did researchers investigate?
Researchers compared Venlafaxine and Lithium Carbonate to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 90
- Sponsor
- Stanley Medical Research Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00641927
- Official title
Show the full official title
Acute Antidepressant Therapy in Bipolar II Major Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Questions about this study
What did researchers investigate?
Researchers compared Venlafaxine and Lithium Carbonate to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who is behind this study?
The study sponsor is Stanley Medical Research Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Venlafaxine and Lithium Carbonate.
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
